A SUBMICRON EMULSION AS OCULAR VEHICLE FOR DELTA-8-TETRAHYDROCANNABINOL - EFFECT ON INTRAOCULAR-PRESSURE IN RABBITS

被引:53
作者
MUCHTAR, S
ALMOG, S
TORRACCA, MT
SAETTONE, MF
BENITA, S
机构
[1] HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARM,POB 12065,JERUSALEM,ISRAEL
[2] CHAIM SHEBA MED CTR,INST CLIN TOXICOL & PHARMACOL,IL-52621 TEL HASHOMER,ISRAEL
[3] UNIV PISA,INST PHARMACEUT CHEM,DEPT PHARMACEUT TECHNOL BIOPHARMACEUT,I-56100 PISA,ITALY
关键词
DELTA-8-TETRAHYDROCANNABINOL; SUBMICRON EMULSION; GLAUCOMA; INTRAOCULAR PRESSURE DECREASE; HYPERTENSIVE NORMOTENSIVE RABBITS;
D O I
10.1159/000267160
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
DELTA8-tetrahydrocannabinol (DELTA8-THC), a known antiglaucoma lipophilic drug, was incorporated in a submicron emulsion for ocular administration. The mean droplet size of the emulsion was 130 +/- 41 nm, and no droplet was larger than 400 nm. No change in pH, particle size distribution or zeta potential was noted after sterilization by steam autoclaving or long-term storage over 9 months. An intense and long-lasting intraocular pressure (IOP)-depressant effect was observed after ocular application (50 mul) of the THC emulsion, 0.4% (w/w), to rabbits with ocular hypertension (chymotrypsin model). Lesser effects were observed in normotensive rabbits. No irritation effect of either the emulsion vehicle or THC emulsion on the rabbit eyes was detected. These results underline the promising properties of submicron emulsions as vehicles for lipophilic ophthalmic drugs. The mechanism by which the emulsion induced the marked DELTA8-THC antiglaucoma effect remains unclear. However, the possible involvement of DELTA8-THC systemic absorption in the hypotensive effect induced by the emulsion cannot be excluded and will be the subject of further investigation.
引用
收藏
页码:142 / 149
页数:8
相关论文
共 23 条
[1]   PHYSOSTIGMINE EMULSION - A NEW INJECTABLE CONTROLLED RELEASE DELIVERY SYSTEM [J].
BENITA, S ;
FRIEDMAN, D ;
WEINSTOCK, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 30 (01) :47-55
[2]  
BURNHAM W R, 1983, International Journal of Pharmaceutics (Kidlington), V13, P9
[3]   SYSTEMIC ABSORPTION OF DELTA-9-TETRAHYDROCANNABINOL AFTER OPHTHALMIC ADMINISTRATION TO THE RABBIT [J].
CHIANG, CWN ;
BARNETT, G ;
BRINE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (02) :136-138
[4]  
DHARMA SK, 1986, ACTA OPHTHALMOL, V64, P298
[5]   CANNABINOIDS IN GLAUCOMA .2. THE EFFECT OF DIFFERENT CANNABINOIDS ON INTRAOCULAR-PRESSURE OF THE RABBIT [J].
ELSOHLY, MA ;
HARLAND, EC ;
BENIGNI, DA ;
WALLER, CW .
CURRENT EYE RESEARCH, 1984, 3 (06) :841-850
[6]   A GAMMA-SCINTIGRAPHIC EVALUATION OF THE PRECORNEAL RESIDENCE OF LIPOSOMAL FORMULATIONS IN THE RABBIT [J].
FITZGERALD, P ;
HADGRAFT, J ;
WILSON, CG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (06) :487-490
[7]  
GREEN K, 1982, ARCH OPHTHALMOL-CHIC, V100, P265
[8]   INTRAOCULAR-PRESSURE FOLLOWING SYSTEMIC ADMINISTRATION OF CANNABINOIDS [J].
GREEN, K ;
SYMONDS, CM ;
OLIVER, NW ;
ELIJAH, RD .
CURRENT EYE RESEARCH, 1982, 2 (04) :247-253
[9]   MARIHUANA AND THE EYE - A REVIEW [J].
GREEN, K .
JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY, 1982, 1 (01) :3-32
[10]   LASER SELECTED FLUORESCENCE OF HUMAN CATARACTOUS LENSES AT LIQUID-HELIUM TEMPERATURES [J].
HANSON, DM ;
ONDRUSKA, O ;
STRUBINGER, LM ;
LAL, BB .
EXPERIMENTAL EYE RESEARCH, 1983, 37 (02) :145-151